How to Buy Sensus Healthcare Stock
Sensus Healthcare Inc
Sensus Healthcare, Inc. , a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide.
Sensus Healthcare stock last closed at $4.81, down 3.22% from the previous day, and has decreased 10.59% in one year. It has overperformed other stocks in the Medical Devices industry by 0.06 percentage points. Sensus Healthcare stock is currently +19.95% from its 52-week low of $4.01, and -48.44% from its 52-week high of $9.33.
There are currently 16.45M shares of SRTS outstanding. The market cap of SRTS is $79.10M. In the last 24 hours, 46,500 SRTS shares were traded.
How to Buy Sensus Healthcare Stock
Not sure how to invest in Sensus Healthcare stock? Here's how.
- Decide where to buy Sensus Healthcare stock: You need to pick a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you figure out where to buy Sensus Healthcare stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Put funds into your investment account: Pick your payment method and add your info.
- Analyze Sensus Healthcare stock: The Sensus Healthcare ticker symbol is SRTS. Is Sensus Healthcare stock a good investment? Should you buy shares of SRTS? How do SRTS's underlying business fundamentals look? Do top analysts think Sensus Healthcare is a good buy? Why has SRTS's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if SRTS is a good stock to buy).
- Make your SRTS buy order: Decide if you will purchase SRTS shares at the current market price or use a limit order to buy SRTS stock at a specific price.
- Keep an eye on your SRTS position: Create a watchlist to get live updates on your new investment in Sensus Healthcare shares.
Step 1: Decide where to buy Sensus Healthcare stock
You will need a brokerage account in order to access the NASDAQ market and buy SRTS shares.
Our favorite brokerage: eToro
We believe that eToro is the best place to buy stocks. Here's why:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global financial markets: From Tech to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen the right brokerage, it's time to fill out some personal info so you are able to buy SRTS today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to create a new trading account.
- Submit your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you have created your account on mobile trading apps, you need to deposit funds:
Watch the tutorial below for more details transferring money into your new brokerage account.
Step 4: Analyze Sensus Healthcare stock
Once you have identified the best place to buy Sensus Healthcare stock, it's absolutely critical to research their stock prior to investing, so you can understand the risk and opportunity.
Sensus Healthcare stock at a glance
Sensus Healthcare Due Diligence Score
WallStreetZen was created to help average investors do better fundamental analysis in less time.
You can see all of the due diligence checks on SRTS's stock page.
What is the fair value of SRTS stock?
You can use many financial metrics, analyses, models, and charts to gauge SRTS's intrinsic value.
Using relative valuations measures:
- SRTS could be overvalued based on its P/E ratio of 43.73x, relative to Medical Devices industry P/E ratio of 35.6x
- SRTS may be undervalued based on its P/B ratio of 1.49x, relative to Medical Devices industry P/B ratio of 3.99x
- SRTS could be overvalued based on its PEG ratio of 1.32x
You can access more valuation research on SRTS's stock here.
SRTS Financial Summary
Pros:
- SRTS has a low debt to equity ratio of 0.14.
- SRTS earnings of $3.46M is not sufficient to cover its interest payments.
- SRTS's operating cash flow of $4.68M allows it to safely service it's debt of $654.00k.
- There are more short-term assets than long-term liabilities on the SRTS balance sheet.
- There are more short-term assets than short-term liabilities on the SRTS balance sheet.
- Total SRTS debt is lower than 5 years ago, relative to shareholder equity.
Cons:
- SRTS profit margin has gone down from 14.7% to 4.6% in the past year.
Do Wall Street analysts think it's a good time to buy SRTS stock
Out of 3 Wall Street analysts who monitor SRTS, the consensus analyst rating on SRTS is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Sensus Healthcare stock forecast page.
SRTS Momentum
SRTS Performance Metrics
Last year, SRTS earnings were $1.80M. In the last 3 year, SRTS's earnings have increased by -97.05% per year. This was slower than the Medical Devices industry average of 12.15%.
Last year, SRTS revenue was $39.49M. In the last 5 year, SRTS's revenue has increased by 10.93% per year. This was faster than the Medical Devices industry average of 9.62%.
Dive into SRTS's earnings and revenue performance here.
Are SRTS executives and large shareholders buying or selling the stock?
Over the past 12 months, executives and large shareholders at SRTS have sold more shares than they have bought.
Javier Rampolla, CHIEF FINANCIAL OFFICER of SRTS, was the latest SRTS insider to buy. They bought $2,980.95 worth of SRTS stock on Feb 10, 2025.
Dig into more about who owns SRTS shares here.
Does SRTS stock generate passive income?
No, Sensus Healthcare doesn't provide an income stream by paying out dividends.
What others are saying about SRTS
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your SRTS buy order
You have two main order types:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are mostly sufficient. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a specific price limit, use a limit order.
Click the Open Trade button and your broker will execute your order.
If you need additional help buying stocks on eToro, click the helpful video below:
Step 6: Keep an eye on your SRTS position
Now that you own some SRTS stock, you'll want to stay up-to-date on your stock purchase.
Make a watchlist to monitor your SRTS stock.
SRTS Feed
How to Buy Stock in Sensus Healthcare
To reiterate, here are the 6 steps for buying Sensus Healthcare stock:
- Decide where to buy Sensus Healthcare stock
- Create your brokerage account
- Put funds into your investment account
- Analyze Sensus Healthcare stock
- Make your SRTS buy order
- Keep an eye on your SRTS position
If you are looking for a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get the latest scoop on your investment in Sensus Healthcare, hit the button below to create your watchlist.
Trending Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.